Cronos Group Inc. (CRON) vs Pacira BioSciences, Inc. (PCRX)
- Cronos Group Inc. CRON 3.22 +0.63%
- Pacira BioSciences, Inc. PCRX 36.35 +0.06%
Cronos Group Inc. and Pacira BioSciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Pacira BioSciences, Inc. is the larger, with a market value of $1.5B against $1.2B — 1.2× the size. Cronos Group Inc. trades at the lower P/E: 16.1× against 104×. Cronos Group Inc. grew revenue faster over the last twelve months: 37.5% against 5.71%. Cronos Group Inc. has the higher net margin (20.9% vs 1.96%) and the lower return on invested capital (−0.34% vs 1.58%). Across the 22 metrics below, Cronos Group Inc. leads on 13 and Pacira BioSciences, Inc. on 9.
Valuation
Profitability
| Metric | CRON | PCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 45.86% | 79.21% | 53.94% |
| Operating margin | (0.96%) | 2.66% | 0.00% |
| Net margin | 20.91% | 1.96% | 0.00% |
| Free cash flow margin | 27.61% | 24.06% | 0.00% |
| Return on equity | 3.33% | 2.05% | (0.40%) |
| Return on assets | 3.18% | 1.05% | (3.32%) |
| Return on invested capital | (0.34%) | 1.58% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack